Summary of Study ST003557
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002191. The data can be accessed directly via it's Project DOI: 10.21228/M8DN9K This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003557 |
Study Title | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- mice administered PBS or N-methyl-arginine (80 mg/kg) via a single intraperitoneal injection. |
Study Summary | Metabolite analysis of kidney, brain, liver, and plasma isolated from Aldh7a1-/- mice fed diets consisting of 0.9% w/w lysine and 18 ppm pyridoxine. Tissues were cryo-homogenized using a liquid nitrogen cooled mortar and pestle into a fine powder and approximately 25-50 mg of each tissue was transferred to a pre-weighed homogenization tube to which ~20 2.3 mm zirconia beads and 1 mL of 80% ice cold methanol were added. Tissues were homogenized using a bead mill and cleared by centrifugation at 4C, where each of the 3-4 cycles consisted of a 60 second homogenization at 6 m/s followed by a 30 second pause. A volume equivalent to 25 mg of tissue extract was transferred to a new tube, and 250 µL of 80% methanol containing 1 µL of stable isotope-labeled internal amino acid standard mix was added. Metabolites were concentrated using a SpeedVac until dry. For plasma metabolite analysis, 10 µL of plasma was added to 250 µL of 80% methanol containing 1 µl of stable isotope-labeled internal amino acid standard mix, vortexed at 4C for 10 minutes, and centrifuged. 0.9 ml of supernatant was transferred to a new tube and concentrated using a SpeedVac until dry. Metabolites were reconstituted into 25-50 µL of water, vortexed, centrifuged, and transferred to vials for analysis by LCMS. LCMS was performed using a ZIC-pHILIC LC column coupled to a Vanquish LC and a flow gradient consisting of 10 mM ammonium carbonate in water and pure acetonitrile. The LC was coupled to an Exploris 240 mass spectrometer operated in a polarity switching data-dependent Top 5 mode. Full MS scan parameters for both positive and negative mode were set to 67-1000 m/z at a resolution of 120k and ddMS2 were collected at a resolution of 30k. |
Institute | University of British Columbia |
Department | Biochemistry & Molecular Biology |
Laboratory | Parker laboratory |
Last Name | Parker |
First Name | Seth |
Address | 950 W 28th Ave, Vancouver, British Columbia, V6H 0B3, Canada |
seth.parker@bcchr.ca | |
Phone | 6048753121 |
Submit Date | 2024-11-01 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2024-11-15 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR002191 |
Project DOI: | doi: 10.21228/M8DN9K |
Project Title: | N-methyl-arginine is taken up into the liver, brain, and kidney of mice. |
Project Type: | Manuscript |
Project Summary: | N-methyl-arginine was identified as a transported substrate through multiple cationic amino acid transporters, which facilitate the uptake of lysine, arginine, and other structurally related amino acids. In cell culture, N-methyl-arginine inhibits the uptake and metabolism of lysine. In this project, we aimed to determine if N-methyl-arginine administered to mice at 80 mg/kg was sufficient to inhibit tissue lysine uptake and metabolism. Following a single injection, N-methyl-arginine significantly accumulated in mouse plasma and tissues but failed to significantly inhibit the level of lysine metabolites (e.g., saccharopine). These results are in-line with in vitro results suggesting that N-methyl-arginine is a relatively low affinity transport inhibitor. |
Institute: | University of British Columbia |
Department: | Biochemistry & Molecular Biology |
Laboratory: | Parker laboratory |
Last Name: | Parker |
First Name: | Seth |
Address: | 950 W 28th Ave, Vancouver, British Columbia, V6H 0B3, Canada |
Email: | seth.parker@bcchr.ca |
Phone: | 6048753121 |
Subject:
Subject ID: | SU003686 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Gender: | Male and female |
Animal Feed: | 0.9% w/w lysine, 18 ppm pyridoxine (standard diets) |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Genotype | Treatment | Sample source |
---|---|---|---|---|
SA388565 | 4 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Brain |
SA388566 | 6 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Brain |
SA388567 | 8 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Brain |
SA388568 | 10 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Brain |
SA388569 | 2 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Brain |
SA388570 | 28 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Kidney |
SA388571 | 22 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Kidney |
SA388572 | 24 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Kidney |
SA388573 | 26 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Kidney |
SA388574 | 18 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Liver |
SA388575 | 16 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Liver |
SA388576 | 20 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Liver |
SA388577 | 14 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Liver |
SA388578 | 12 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Liver |
SA388579 | 34 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Plasma |
SA388580 | 36 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Plasma |
SA388581 | 38 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Plasma |
SA388582 | 40 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Plasma |
SA388583 | 32 | Aldh7a1-/- | N-methyl-arginine (80 mg/kg) | Plasma |
SA388584 | 1 | Aldh7a1-/- | PBS | Brain |
SA388585 | 3 | Aldh7a1-/- | PBS | Brain |
SA388586 | 5 | Aldh7a1-/- | PBS | Brain |
SA388587 | 7 | Aldh7a1-/- | PBS | Brain |
SA388588 | 9 | Aldh7a1-/- | PBS | Brain |
SA388589 | 21 | Aldh7a1-/- | PBS | Kidney |
SA388590 | 23 | Aldh7a1-/- | PBS | Kidney |
SA388591 | 25 | Aldh7a1-/- | PBS | Kidney |
SA388592 | 27 | Aldh7a1-/- | PBS | Kidney |
SA388593 | 29 | Aldh7a1-/- | PBS | Kidney |
SA388594 | 19 | Aldh7a1-/- | PBS | Liver |
SA388595 | 13 | Aldh7a1-/- | PBS | Liver |
SA388596 | 15 | Aldh7a1-/- | PBS | Liver |
SA388597 | 17 | Aldh7a1-/- | PBS | Liver |
SA388598 | 11 | Aldh7a1-/- | PBS | Liver |
SA388599 | 33 | Aldh7a1-/- | PBS | Plasma |
SA388600 | 31 | Aldh7a1-/- | PBS | Plasma |
SA388601 | 35 | Aldh7a1-/- | PBS | Plasma |
SA388602 | 37 | Aldh7a1-/- | PBS | Plasma |
SA388603 | 39 | Aldh7a1-/- | PBS | Plasma |
Showing results 1 to 39 of 39 |
Collection:
Collection ID: | CO003679 |
Collection Summary: | Liver, brain, kidney, or plasma samples collected from mice treated with PBS or N-methyl-arginine (80 mg/kg) as a single intraperitoneal injection. Tissues collected 7-hours after injection. |
Sample Type: | Tissue or Plasma |
Treatment:
Treatment ID: | TR003695 |
Treatment Summary: | Mice were administered a single intraperitoneal injection containing either saline or N-methyl-arginine (80 mg/kg). 7-hours after the injection, the mice were euthanized by cardiac puncture, and tissues were isolated for analysis by LCMS. |
Treatment Compound: | N-methyl-arginine |
Treatment Route: | Intraperitoneal |
Treatment Dose: | 80 mg/kg |
Treatment Vehicle: | PBS |
Sample Preparation:
Sampleprep ID: | SP003693 |
Sampleprep Summary: | Dried samples were reconstituted in 50 µL of HPLC-grade water. Samples were vortexed for ~10 minutes, then centrifuged at 21,000 x g for 15 min at 4°C. 40 microliters were transferred to LC vials containing glass inserts for analysis. |
Combined analysis:
Analysis ID | AN005847 | AN005848 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | HILIC | HILIC |
Chromatography system | Thermo Vanquish | Thermo Vanquish |
Column | Merck SeQuant ZIC-pHILIC (150 x 2.1mm, 5µm) | Merck SeQuant ZIC-pHILIC (150 x 2.1mm, 5µm) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Exploris 240 | Thermo Exploris 240 |
Ion Mode | POSITIVE | NEGATIVE |
Units | Ion counts | Ion counts |
Chromatography:
Chromatography ID: | CH004440 |
Instrument Name: | Thermo Vanquish |
Column Name: | Merck SeQuant ZIC-pHILIC (150 x 2.1mm, 5µm) |
Column Temperature: | 25°C |
Flow Gradient: | 80-20%B (0-30 min), 20-20%B (30-40 minute), and 20-80%B (40-40.5 minute); the LC column was re-equilibrated using 80-80%B from 40.5-52 minute before subsequent injections |
Flow Rate: | 100 µL/min |
Solvent A: | 100% Water; 10 mM Ammonium Carbonate, pH 9.0 |
Solvent B: | 100% Acetonitrile |
Chromatography Type: | HILIC |
MS:
MS ID: | MS005567 |
Analysis ID: | AN005847 |
Instrument Name: | Thermo Exploris 240 |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | The LC was coupled to a Thermo Scientific Exploris 240 mass spectrometer operating in heated electrospray ionization mode (HESI) for analysis. The following parameters were set for HESI: spray voltage 3.4 kV (positive) and 2 kV (negative), static spray voltage, sheath gas 25, aux gas 5, sweep gas 0.5, ion transfer tube temperature 320°C, and vaporizer temperature 75°C. The global parameters included an expected peak width of 20 seconds, mild trapping, and a default charge state of 1. A 40-min polarity switching data-dependent Top 5 method was used for positive mode and a data-dependent Top 3 method was used for negative mode. Full MS scan parameters for both positive and negative modes were set as follows: scan range 67-1000 m/z collected in profile mode, Orbitrap resolution 120,000, RF lens 70%, AGC target of 300%, and maximum injection time set to automatic. ddMS2 for positive mode were collected in centroid mode at an Orbitrap resolution of 30,000, isolation window of 1.5 m/z, an AGC target set to standard, a maximum injection time set to automatic, and a normalized collision energy set to 10%, 30%, and 80%. ddMS2 for negative mode were collected in centroid mode at an Orbitrap resolution of 30,000, isolation window of 2 m/z, an AGC target set to standard, a maximum injection time set to automatic, and a normalized collision energy set to 30%. For both positive and negative ddMS2, we applied an intensity threshold of 5e4 and a dynamic exclusion of 5 ppm for 10 seconds, excluding isotopes. A targeted selected ion monitoring (tSIM) scan was also included for pipecolate and P6C/P2C, and the retention time ranges were based on elution of authentic standards (pipecolate) or from positive samples (Aldh7a1-deficient tissues). The tSIM scan for pipecolate was collected from 8-12 minutes in negative mode at an isolation window of 4 m/z (for metabolomics) or 18 m/z (for isotope-tracing experiments, to include m/z shifts), an Orbitrap resolution of 120,000, a RF lens at 70%, an automatic maximum injection time, and collected in profile mode. The tSIM scan for P6C/P2C was collected from 6-10 minutes in positive mode at an isolation window of 4 m/z (for metabolomics) or 18 m/z (for isotope-tracing experiments, to include m/z shifts), an Orbitrap resolution of 120,000, a RF lens at 70%, an automatic maximum injection time, and collected in profile mode. |
Ion Mode: | POSITIVE |
MS ID: | MS005568 |
Analysis ID: | AN005848 |
Instrument Name: | Thermo Exploris 240 |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | The LC was coupled to a Thermo Scientific Exploris 240 mass spectrometer operating in heated electrospray ionization mode (HESI) for analysis. The following parameters were set for HESI: spray voltage 3.4 kV (positive) and 2 kV (negative), static spray voltage, sheath gas 25, aux gas 5, sweep gas 0.5, ion transfer tube temperature 320°C, and vaporizer temperature 75°C. The global parameters included an expected peak width of 20 seconds, mild trapping, and a default charge state of 1. A 40-min polarity switching data-dependent Top 5 method was used for positive mode and a data-dependent Top 3 method was used for negative mode. Full MS scan parameters for both positive and negative modes were set as follows: scan range 67-1000 m/z collected in profile mode, Orbitrap resolution 120,000, RF lens 70%, AGC target of 300%, and maximum injection time set to automatic. ddMS2 for positive mode were collected in centroid mode at an Orbitrap resolution of 30,000, isolation window of 1.5 m/z, an AGC target set to standard, a maximum injection time set to automatic, and a normalized collision energy set to 10%, 30%, and 80%. ddMS2 for negative mode were collected in centroid mode at an Orbitrap resolution of 30,000, isolation window of 2 m/z, an AGC target set to standard, a maximum injection time set to automatic, and a normalized collision energy set to 30%. For both positive and negative ddMS2, we applied an intensity threshold of 5e4 and a dynamic exclusion of 5 ppm for 10 seconds, excluding isotopes. A targeted selected ion monitoring (tSIM) scan was also included for pipecolate and P6C/P2C, and the retention time ranges were based on elution of authentic standards (pipecolate) or from positive samples (Aldh7a1-deficient tissues). The tSIM scan for pipecolate was collected from 8-12 minutes in negative mode at an isolation window of 4 m/z (for metabolomics) or 18 m/z (for isotope-tracing experiments, to include m/z shifts), an Orbitrap resolution of 120,000, a RF lens at 70%, an automatic maximum injection time, and collected in profile mode. The tSIM scan for P6C/P2C was collected from 6-10 minutes in positive mode at an isolation window of 4 m/z (for metabolomics) or 18 m/z (for isotope-tracing experiments, to include m/z shifts), an Orbitrap resolution of 120,000, a RF lens at 70%, an automatic maximum injection time, and collected in profile mode. |
Ion Mode: | NEGATIVE |